#1 Clinical Trials Search in Europe

L-Tyrosine

L-Tyrosine, an amino acid, is being studied in clinical trials for its potential benefits in treating various conditions. These trials aim to investigate the effects of L-Tyrosine on muscle disorders, brain imaging, decision-making under stress, recovery from operational strain, and as a component in brain tumor imaging. The research explores how L-Tyrosine supplementation might impact cognitive function, stress response, and diagnostic capabilities in different medical contexts.

Table of Contents

What is L-Tyrosine?

L-Tyrosine is an amino acid that plays a crucial role in the human body. It is a chemical precursor of dopamine, which means it helps in the production of this important neurotransmitter[1]. Dopamine is involved in various brain functions, including mood regulation, motivation, and cognitive processes.

Potential Applications of L-Tyrosine

Research is ongoing to explore the potential benefits of L-Tyrosine in various medical applications. These studies aim to understand how this compound might help in different health conditions and situations.

L-Tyrosine in Brain Imaging

One interesting application of L-Tyrosine is in brain imaging, particularly for detecting and assessing brain tumors. A modified form of L-Tyrosine, called O-(2-[18F]fluoroethyl)-L-tyrosine (FET), is being studied as a tracer for Positron Emission Tomography (PET) scans[2].

This technique is being investigated for:

  • Diagnosing low-grade gliomas (a type of brain tumor)
  • Improving the accuracy of tumor biopsies
  • Better defining the boundaries between healthy and tumor tissues

Researchers hope that this method will lead to more precise diagnoses and potentially help in planning more effective treatments for brain tumors[3].

L-Tyrosine for Nemaline Myopathy

L-Tyrosine is also being studied as a potential treatment for a rare muscle disorder called nemaline myopathy. Specifically, researchers are investigating its effects on a form of the disease caused by mutations in the TNNT1 gene[4].

While the exact mechanisms are not fully understood, scientists hope that L-Tyrosine supplementation might improve some symptoms of this condition. However, more research is needed to confirm its effectiveness and safety for this use.

L-Tyrosine in Stress Management

L-Tyrosine’s role in dopamine production has led researchers to explore its potential in managing stress and improving cognitive function under stressful conditions[1].

Studies are investigating whether L-Tyrosine supplementation can:

  • Improve decision-making in stressful situations
  • Enhance cognitive performance under stress
  • Help maintain dopamine levels during periods of increased stress

These studies involve exposing participants to stressful conditions and measuring their performance on various cognitive tasks after taking either L-Tyrosine or a placebo.

L-Tyrosine for Recovery from Operational Strain

Another area of research focuses on the potential of L-Tyrosine to help individuals recover from operational strain. This term refers to the chronic stress and physical demands experienced by people in high-stress occupations, such as military personnel[5].

Researchers are investigating whether L-Tyrosine supplementation can:

  • Aid in recovery after periods of intense operational stress
  • Reduce the risk of burnout
  • Help restore normal physiological functions after prolonged stress exposure

These studies involve measuring various biological markers and using psychological questionnaires to assess the effects of L-Tyrosine supplementation.

Safety Considerations

While L-Tyrosine shows promise in various applications, it’s important to note that these are still areas of active research. The safety and effectiveness of L-Tyrosine supplementation for these purposes have not been fully established.

Always consult with a healthcare professional before starting any new supplement regimen, especially if you have existing health conditions or are taking other medications.

Aspect Details
Conditions Studied TNNT1 myopathy, low-grade glioma, stress-related decision making, operational strain recovery, high-grade glioma imaging
Administration Methods Oral capsules, injectable PET tracers
Dosages Varies by study (e.g., 500 mg capsules, 5 mCi for imaging)
Study Designs Double-blind placebo-controlled, crossover trials, feasibility studies
Outcome Measures Cognitive task performance, burnout scores, blood biomarkers, PET imaging results
Duration of Studies Ranging from single imaging sessions to 24-month follow-ups
Potential Benefits Improved cognitive function under stress, better diagnostic imaging for brain tumors, muscle function improvement

FAQ

  • What conditions are being studied with L-Tyrosine in these clinical trials? The clinical trials are studying L-Tyrosine for various conditions including TNNT1 myopathy (a muscle disorder), low-grade glioma (a type of brain tumor), stress-related decision making, recovery from operational strain in soldiers, and as a component in imaging high-grade gliomas.
  • How is L-Tyrosine being used in brain imaging studies? L-Tyrosine is being used in brain imaging studies as a component of tracers for Positron Emission Tomography (PET) scans. For example, O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) is being evaluated for its ability to diagnose and assess low-grade gliomas and high-grade gliomas.
  • What are the potential benefits of L-Tyrosine supplementation in stress-related studies? L-Tyrosine supplementation is being studied for its potential to improve decision-making under stress and aid in recovery from operational strain. It's thought that L-Tyrosine might help restore dopamine levels in the brain, which can be depleted during stressful situations.
  • How is L-Tyrosine administered in these clinical trials? In the trials, L-Tyrosine is administered in various ways depending on the study. For oral supplementation, it's given as capsules (e.g., 500 mg capsules). In imaging studies, it's used as a component of injectable tracers for PET scans.
  • Are there any known side effects of L-Tyrosine supplementation mentioned in these trials? The clinical trials data provided doesn't specifically mention side effects of L-Tyrosine supplementation. However, the studies include monitoring for adverse events, suggesting that patient safety is being closely observed throughout the trials.

Ongoing Clinical Trials on L-Tyrosine

  • Study on Ketoanalogue Supplementation for Muscle Protection in Patients with Stage 4 and 5 Chronic Kidney Disease on a Low Protein Diet

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effectiveness of Ketoanalogues in Preventing Muscle Loss in Patients with Nephrotic Syndrome

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Ketosteril Added to Usual Nutrition for Patients Starting Incremental Haemodialysis with Incremental Haemodialysis

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Impact of Acetylcysteine and Drug Combination on Kidney Function in Living Donor Kidney Transplant Patients

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • L-Tyrosine: An amino acid that is a precursor to neurotransmitters like dopamine. It's being studied for its potential effects on cognitive function and stress response.
  • TNNT1 myopathy: A rare genetic muscle disorder that affects muscle strength and function.
  • Glioma: A type of tumor that occurs in the brain and spinal cord, arising from glial cells.
  • Positron Emission Tomography (PET): An imaging technique that uses radioactive tracers to visualize and measure metabolic processes in the body.
  • FET (O-(2-[18F]Fluoroethyl)-L-tyrosine): A radioactive tracer used in PET imaging, particularly for brain tumors, that is based on the structure of L-Tyrosine.
  • Operational strain: The physical and mental stress experienced by individuals, particularly soldiers, during prolonged periods of demanding operational conditions.
  • Allostatic load: The cumulative wear and tear on the body's systems due to chronic stress and adaptation to environmental challenges.
  • Dopamine: A neurotransmitter in the brain that plays a role in motivation, reward, and cognitive function.
  • Catecholamine: A class of hormones produced by the adrenal glands, including dopamine, norepinephrine, and epinephrine, involved in the body's stress response.
  • Brain-Derived Neurotrophic Factor (BDNF): A protein that supports the survival of existing neurons and encourages the growth and differentiation of new neurons and synapses.

References

  1. https://clinicaltrials.gov/study/NCT04518254
  2. https://clinicaltrials.gov/study/NCT02286531
  3. https://clinicaltrials.gov/study/NCT05632562
  4. https://clinicaltrials.gov/study/NCT02035501
  5. https://clinicaltrials.gov/study/NCT04549194